Kivlighn S - Search Results

1

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.

Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Mazzali M, et al. Among authors: kivlighn s. Hypertension. 2001 Nov;38(5):1101-6. doi: 10.1161/hy1101.092839. Hypertension. 2001. PMID: 11711505

2

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Johnson RJ, et al. Among authors: kivlighn s. Hypertension. 2003 Jun;41(6):1183-90. doi: 10.1161/01.HYP.0000069700.62727.C5. Epub 2003 Apr 21. Hypertension. 2003. PMID: 12707287 Review.

3

Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.

Kim YG, Huang XR, Suga S, Mazzali M, Tang D, Metz C, Bucala R, Kivlighn S, Johnson RJ, Lan HY. Kim YG, et al. Among authors: kivlighn s. Mol Med. 2000 Oct;6(10):837-48. Mol Med. 2000. PMID: 11126199 Free PMC article.

4

Hyperuricemia exacerbates chronic cyclosporine nephropathy.

Mazzali M, Kim YG, Suga S, Gordon KL, Kang DH, Jefferson JA, Hughes J, Kivlighn SD, Lan HY, Johnson RJ. Mazzali M, et al. Among authors: kivlighn sd. Transplantation. 2001 Apr 15;71(7):900-5. doi: 10.1097/00007890-200104150-00014. Transplantation. 2001. PMID: 11349724

5

Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.

Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Johnson RJ, et al. Among authors: kivlighn sd. Am J Kidney Dis. 1999 Feb;33(2):225-34. doi: 10.1016/s0272-6386(99)70295-7. Am J Kidney Dis. 1999. PMID: 10023633 Review.

6

Serum uric acid and cardiovascular events in successfully treated hypertensive patients.

Alderman MH, Cohen H, Madhavan S, Kivlighn S. Alderman MH, et al. Among authors: kivlighn s. Hypertension. 1999 Jul;34(1):144-50. doi: 10.1161/01.hyp.34.1.144. Hypertension. 1999. PMID: 10406838

7

Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines?

Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt DA, Gaillard CA. Hall JE, et al. Among authors: kivlighn sd. Hypertension. 1990 May;15(5):519-27. doi: 10.1161/01.hyp.15.5.519. Hypertension. 1990. PMID: 2185153

8

Effects of aging and AT-1 receptor blockade on NO synthase expression and renal function in SHR.

Vaziri ND, Wang XQ, Ni ZN, Kivlighn S, Shahinfar S. Vaziri ND, et al. Among authors: kivlighn s. Biochim Biophys Acta. 2002 Oct 21;1592(2):153-61. doi: 10.1016/s0167-4889(02)00309-9. Biochim Biophys Acta. 2002. PMID: 12379478 Free article.

9

Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension.

Ni Z, Bemanian S, Kivlighn SD, Vaziri ND. Ni Z, et al. Among authors: kivlighn sd. Kidney Int. 1998 Jul;54(1):188-92. doi: 10.1046/j.1523-1755.1998.00987.x. Kidney Int. 1998. PMID: 9648078 Free article.

10

Chronic effects of a physiological dose of ANP on arterial pressure and renin release.

Kivlighn SD, Lohmeier TE, Yang HM, Shin Y. Kivlighn SD, et al. Am J Physiol. 1990 May;258(5 Pt 2):H1491-7. doi: 10.1152/ajpheart.1990.258.5.H1491. Am J Physiol. 1990. PMID: 2140022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page